Dr Meghan McIlwain, Clinical Research Manager
President, The New Zealand Association of Clinical Research,
AUCKLAND, NEW ZEALAND
Bench Side Story continues with a Clinical Research Manager, and President of New Zealand Association of Clinical Research based in Auckland, NEW ZEALAND.
Dr Meghan McIlwain is a Clinical Research Manager, the President of the New Zealand Association of Clinical Research, a pharmacist and a guest lecturer at the University of Auckland School of Pharmacy. Through her career she’s been a hospital pharmacist, a community pharmacist, a postgraduate student, a postdoctoral researcher, a lecturer and an independent research consultant. Her PhD in is Pharmacy; specifically neuropsychopharmacology.
-
Professor Christoph Hagemeyer
RESEARCH IN NANOBIOTECHNOLOGY
@ MONASH UNIVERSITY
VICTORIA, AUSTRALIA -
Nutraceutical and pharmacological intervention in neurological disorders
Dr Virginie Lam is a neuroscientist and cerebrovascular biologist with over 15 years of research experience, including more than seven years post-PhD. She co-leads the Neurovascular and Metabolic Diseases Laboratory at the Curtin Medical Research Institute and holds an affiliate appointment at the Perron Institute for Neurological and Translational Science. Her research focuses on the interface between neurovascular health, cognitive function, and therapeutic translation in neurodegenerative disorders.
-
Personalised approaches to lung therapy
Dr. Adams’ research focus is on lung cancer, which is the deadliest of all cancers worldwide. He is working towards developing personalised approaches to pinpoint a therapy that is going to be most effective for the person with that disease. Dr. Adams’ research is focusing on chemotherapy and targeted therapy, and he is trying to identify upfront which of those tumours are likely to be resistant to the therapy. He then identifies strategies that will resensitize or increase the sensitivity of the tumour to the standard of care that is targeted therapy or chemotherapy.
